Douglas CDMO: End-To-End Pharmaceutical Solutions With A Softgel Specialty

Douglas CDMO offers comprehensive contract development and manufacturing services, guiding pharmaceutical products from early development through to commercial-scale production. With a legacy of innovation dating back to 1967, our Auckland-based, state-of-the-art facility supports GMP manufacturing, packaging, quality control, and distribution — all under one roof.

We specialize in high-potency small molecule pharmaceuticals and are global leaders in softgel capsule development, having contributed to roughly one-third of the softgels on the EU and US markets. Our integrated services include pre-formulation, analytical testing, and regulatory support, helping clients navigate every phase of the product lifecycle with confidence. By leveraging New Zealand’s clinical trial advantages — including faster approvals and R&D incentives — we deliver high-quality, cost-effective solutions to accelerate your path to market.